Mesalamine DR 400 MG capsule 180S
Ended Awarded
- Contract number
- SPE2DB25FH1Q8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,820
Award facts
- Contract value 100% obligated
- $17,820.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,820.21 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units) with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mesalamine is a pharmaceutical treatment primarily used for inflammatory bowel conditions, reflecting the Defense Logistics Agency's ongoing procurement of medications supporting military and veteran healthcare needs.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen serves multiple government healthcare systems including the Defense Health Agency and U.S. Coast Guard through this flexible contract vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and various medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FH1Q8?
SPE2DB25FH1Q8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FH1Q8 worth?
The government has obligated $17,820 on SPE2DB25FH1Q8.
Is contract SPE2DB25FH1Q8 an order under another contract?
Yes. SPE2DB25FH1Q8 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FH1Q8 competed?
The extent of competition for SPE2DB25FH1Q8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award